CARDIOGEN SCIENCES
CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.
CARDIOGEN SCIENCES
Social Links:
Industry:
Biotechnology Genetics Medical
Founded:
2014-01-01
Address:
Palo Alto, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
526 K USD
Similar Organizations
Current Advisors List
Founder
Investors List
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Seed Round - CardioGen Sciences
More informations about "CardioGen Sciences"
CardioGen Sciences Company Profile 2024: Valuation, Investors ...
CardioGen Sciences is a Private company. What is CardioGen Sciencesโs current revenue? โฆSee details»
CardioGen Sciences - Funding, Financials, Valuation & Investors
Organization. CardioGen Sciences . Connect to CRM . Save . Summary. Financials. People. โฆSee details»
Cardiogen Sciences, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 13, 2023 Explore Cardiogen Sciences, Inc. with its drug pipeline, therapeutic area, โฆSee details»
Cardiogen Sciences - Ownership and Business Overview - Mergr
Sep 1, 2015 Cardiogen Sciences was founded in 2014. Life Science M&A Summary in 2015 โฆSee details»
Cardiogen Sciences - Products, Competitors, Financials, Employees ...
Sep 1, 2015 Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen โฆSee details»
CardioGen Sciences acquired by Audentes Therapeutics
CardioGen Sciences Developing gene therapy solutions for orphan inherited arrhythmogenic โฆSee details»
Audentes Therapeutics Acquires Cardiac Gene Therapy Company โฆ
Sep 1, 2015 Cardiogen was founded in 2014 by Louis G. Lange, MD, PhD to translate the โฆSee details»
San Francisco's Audentes Inks Deal to Buy Cardiogen Sciences
Sep 1, 2015 Cardiogen, founded in 2014, focuses on therapeutics to treat inherited โฆSee details»
Audentes Therapeutics Acquires Cardiogen Sciences
Sep 1, 2015 Cardiogen was founded last year by Louis G. Lange, M.D., Ph.D., to translate โฆSee details»
Sage Business Cases - Advancing the CardioGen Pipeline
Jan 3, 2022 In addition to preparing quantitative analyses, students will evaluate qualitative โฆSee details»
CardioGen Sciences - Crunchbase
Organization. CardioGen Sciences . Connect to CRM . Save . Summary. Financials. People. โฆSee details»
Cardiogen: Everything You Need to Know About This Bioregulator โฆ
Aug 25, 2023 Cardiogen is a peptide known for its potential influence on fibroblast behaviour, โฆSee details»
Audentes Therapeutics Acquires Cardiac Gene Therapy Company โฆ
Sep 1, 2015 Audentes plans to rapidly advance Cardiogen's lead program for the CASQ2 โฆSee details»
CardioGen Database Offers Genotype Data for Cardiovascular โฆ
Feb 10, 2023 The total number of patients worldwide with monogenic cardiovascular disease โฆSee details»
CardioGen Upgrade Helps Clinicians Accurately Diagnose โฆ
May 23, 2023 CardioGen automated the interpretation process, presenting accurate results โฆSee details»
CardioGen Sciences - Contacts, Employees, Board Members
Organization. CardioGen Sciences . Connect to CRM . Save . Summary. Financials. People. โฆSee details»
CardioGen
CardioGen aimed to aggregate information about genotype-phenotype relation for monogenic โฆSee details»
Cardiogen Peptide: Full Guide For Cardiac Research & Cancer
Cardiogen is suggested to primarily target fibroblasts, cells associated with scar formation and โฆSee details»